Skip to contentKARABELAS ARGERIS N — Vanda Pharmaceuticals Inc. insider: 157 transactions · InsiderLensKARABELAS ARGERIS N
- Director at NITROMED INC · on record since Mar 22, 2006
- Director at ANADYS PHARMACEUTICALS INC · on record since Mar 18, 2004
- Director at HUMAN GENOME SCIENCES INC · on record since Apr 28, 2006
- Chairman at HUMAN GENOME SCIENCES INC · on record since Apr 28, 2006
- Chairman, Interim CEO & Pres. at NITROMED INC · on record since May 19, 2006
- Director at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
- Chairman of the Board at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
- 10% owner at BIODELIVERY SCIENCES INTERNATIONAL INC · on record since Jun 12, 2006
- See remarks below. at BIODELIVERY SCIENCES INTERNATIONAL INC · on record since Jul 23, 2009
- 10% owner at NITROMED INC · on record since Jul 15, 2004
- Director at REGENXBIO Inc. · on record since Jun 2, 2026
- Director at ROCKET PHARMACEUTICALS, INC. · on record since Feb 25, 2015
- 10% owner at ROCKET PHARMACEUTICALS, INC. · on record since Feb 25, 2015
- Director at VALEANT PHARMACEUTICALS INTERNATIONAL · on record since Jun 21, 2016
- Director at BIOVAIL CORP INTERNATIONAL · on record since May 3, 2019
Insider trading activity of KARABELAS ARGERIS N
- Transactions on record
- 157
- since Nov 10, 2003
- Open-market buys
- 3
- $3.9M
- Open-market sells
- 48
- $75.6M
- Companies traded
- 9
- last filing Jun 2, 2026
Figures computed from official regulatory filings — methodology.
Companies where KARABELAS ARGERIS N has traded
- REGENXBIO Inc.38 tx · $923.2K · Jun 2, 2026
- BIOVAIL CORP INTERNATIONAL4 tx · $250K · Jun 28, 2022
- VALEANT PHARMACEUTICALS INTERNATIONAL5 tx · $98.6K · May 8, 2018
- ROCKET PHARMACEUTICALS, INC.6 tx · $3.7M · Jun 26, 2015
- HUMAN GENOME SCIENCES INC27 tx · $2.6M · Aug 1, 2012
- Vanda Pharmaceuticals Inc.48 tx · $73.3M · Jun 17, 2011
- BIODELIVERY SCIENCES INTERNATIONAL INC6 tx · $1.7M · Jun 26, 2009
- NITROMED INC21 tx · Apr 28, 2009
- ANADYS PHARMACEUTICALS INC2 tx · Sep 6, 2005
Track record of KARABELAS ARGERIS N
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of KARABELAS ARGERIS N
Co-insiders of KARABELAS ARGERIS N
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
RUCH JOSHUANITROMED INC +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 2, 2026 | AwardD | 46,600 | 0.00 USD | $0 | SEC |
| Jun 2, 2026 | Award | 9,807 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | AwardD | 39,815 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | Award | 7,768 | 0.00 USD | $0 | SEC |
| Oct 2, 2024 | Exercise | 10,000 | 3.76 USD | $37.6K | SEC |
| Oct 2, 2024 | Sell | -10,000 | 10.11 USD | $101.1K | SEC |
| Oct 2, 2024 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Sep 4, 2024 | Sell | -9,300 | 11.50 USD | $107K | SEC |
| Sep 4, 2024 | Exercise | 10,000 | 3.76 USD | $37.6K | SEC |
| Sep 4, 2024 | Sell | -700 | 12.34 USD | $8.6K | SEC |
| Sep 4, 2024 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | Exercise | 100 | 12.74 USD | $1.3K | SEC |
| Aug 5, 2024 | ExerciseD | -100 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | Sell | -9,600 | 13.45 USD | $129.1K | SEC |
| Aug 5, 2024 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | Sell | -100 | 15.00 USD | $1.5K | SEC |
| Aug 5, 2024 | Sell | -400 | 14.59 USD | $5.8K | SEC |
| Aug 5, 2024 | Exercise | 10,000 | 3.76 USD | $37.6K | SEC |
| Jul 30, 2024 | Sell | -11,000 | 15.05 USD | $165.6K | SEC |
| Jul 30, 2024 | Exercise | 11,000 | 12.74 USD | $140.1K | SEC |
| Jul 30, 2024 | ExerciseD | -11,000 | 0.00 USD | $0 | SEC |
| Jul 3, 2024 | Exercise | 10,000 | 3.76 USD | $37.6K | SEC |
| Jul 3, 2024 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Jul 3, 2024 | Sell | -10,000 | 11.27 USD | $112.7K | SEC |
| Jun 4, 2024 | AwardD | 24,454 | 0.00 USD | $0 | SEC |